Wilmot Cancer Institute leadership has enlisted bright minds from across the nation to come here, to Rochester, as part of a team that pledges to defeat cancer.
Working with zebrafish, Patrick Murphy, Ph.D., wants to understand some of the most fundamental questions in cancer including how cells divide and change inappropriately.
Stephano Mello, Ph.D., has always lived for those “eureka” moments in the lab, but it was a series of personal eureka moments that shifted him toward cancer research.
After a friend died of breast cancer at age 34, Isaac Harris, Ph.D., felt the urgency of his work to better understand how cancer cells grow and resist treatment.
A family history of cancer pushed Rachael Turner, M.D., Ph.D., into an oncology career, where she’s studying an ovarian cancer biomarker, HE4.
Ian Kleckner, Ph.D., M.P.H., has always found the mind-body connection fascinating, and today, his work focuses on discovering whether exercise may help with a common cancer treatment side effect: ...
Michael Giacomelli, Ph.D., has two babies: His daughter, born just as he was setting up his lab in Rochester, and a prized invention, a novel 3D imaging device that helps surgeons detect whether a ...
Ben Frisch, Ph.D., grew up on a dairy farm and is no stranger to hard work. As a researcher, he’s working to understand how cancer impacts healthy bone marrow.
His interest in science started at a young age, and today Thomas Ciucci, Ph.D., wants to better understand T-cells, in hopes of making them better fighters against cancer.
Paul Boutz, Ph.D., thought he’d be a paleontologist until he studied under a prominent RNA biologist and shifted his course toward cancer biology.